✦ LIBER ✦

Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype

✍ Scribed by Itokawa, Norio; Atsukawa, Masanori; Tsubota, Akihito; Kondo, Chisa; Hashimoto, Satomi; Fukuda, Takeshi; Matsushita, Yoko; Kidokoro, Hideko; Kobayashi, Tamaki; Narahara, Yoshiyuki; Nakatsuka, Katsuhisa; Kanazawa, Hidenori; Iwakiri, Katsuhiko; Sakamoto, Choitsu

Book ID: 121373772
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 798 KB
Volume: 28
Category: Article
ISSN: 0815-9319
DOI: 10.1111/jgh.12039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon-alpha 2b–ribavirin

Pegylated interferon-alpha 2b–ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis

✍ M. Derbala; A. Amer; A. Bener; A. C. Lopez; M. Omar; M. El Ghannam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

982 Pegylated interferon alfa-2B in comb

982 Pegylated interferon alfa-2B in combination with ribavirin for the treatment of chronic hepatitis C genotype 4

✍ HASAN, F; ASKER, H; ALKHALDI, J; SIDDIQUE, I; OWAID, S; ALAJMI, M; ALNAKIB, B 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Retreatment with pegylated interferon-al

Retreatment with pegylated interferon-alpha2b plus ribavirin in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ Teuber, Gerlinde; Kallinowski, Birgit; Niederau, Claus; Klinker, Hans; Galle, Pe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Insulin resistance undermines the advant

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1

✍ Eiichi Ogawa; Norihiro Furusyo; Masayuki Murata; Hiroaki Ikezaki; Takeshi Ihara; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 796 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

Controlled trial with pegylated interfer

Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ G. Teuber; B. Kallinowski; C. Niederau; H. Klinker; P.R. Galle; M. Zankel; S. Ze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB